loadpatents
name:-0.045599937438965
name:-0.034761190414429
name:-0.015818119049072
Lim; Jongwon Patent Filings

Lim; Jongwon

Patent Applications and Registrations

Patent applications and USPTO patent grants for Lim; Jongwon.The latest application filed is for "novel arylalkyl pyrazole compounds as indoleamine 2,3-dioxygenase inhibitors".

Company Profile
20.51.69
  • Lim; Jongwon - Lexington MA
  • LIM; JONGWON - Boston MA US
  • LIM; Jongwon - Rahway NJ US
  • Lim; Jongwon - Lexintong MA
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Substituted cyclobutylbenzene compounds as indoleamine 2,3-dioxygenase (IDO) inhibitors
Grant 11,319,283 - McGowan , et al. May 3, 2
2022-05-03
Novel Arylalkyl Pyrazole Compounds As Indoleamine 2,3-dioxygenase Inhibitors
App 20210380572 - Clausen; Dane ;   et al.
2021-12-09
Novel Aryloxypiperidine Pyrazole Compounds As Indoleamine 2,3-dioxygenase Inhibitors
App 20210330676 - Clausen; Dane ;   et al.
2021-10-28
Prmt5 Inhibitors
App 20210309688 - Lim; Jongwon ;   et al.
2021-10-07
Substituted cyclobutylpyridine and cyclobutylpyrimidine compounds as indoleamine 2,3-dioxygenase (IDO) inhibitors
Grant 11,111,232 - White , et al. September 7, 2
2021-09-07
Cyclic Di-nucleotide Compounds As Sting Agonists
App 20210206796 - Andresen; Brian M. ;   et al.
2021-07-08
Sting agonist compounds
Grant 10,793,557 - Altman , et al. October 6, 2
2020-10-06
Novel Substituted Cyclobutylpyridine And Cyclobutylpyrimidine Compounds As Indoleamine 2,3-dioxygenase (ido) Inhibitors
App 20200290996 - White; Catherine M. ;   et al.
2020-09-17
Cyclic di-nucleotide compounds as sting agonists
Grant 10,766,919 - Altman , et al. Sep
2020-09-08
Novel Substituted Cyclobutylbenzene Compounds As Indoleamine 2,3-dioxygenase (ido) Inhibitors
App 20200277252 - McGowan; Meredeth Ann ;   et al.
2020-09-03
Compounds that are ERK inhibitors
Grant 10,759,805 - Lim , et al. Sep
2020-09-01
Cyclic di-nucleotide compounds as STING agonists
Grant 10,759,825 - Altman , et al. Sep
2020-09-01
Benzo[b]thiophene compounds as STING agonists
Grant 10,730,849 - Altman , et al.
2020-08-04
Benzo[b]thiophene compounds as STING agonists
Grant 10,703,738 - Altman , et al.
2020-07-07
Cyclic Di-nucleotide Compounds As Sting Agonists
App 20200062798 - WU; Wen-Lian ;   et al.
2020-02-27
Aryl Sulfonamides As Blt1 Antagonists
App 20190382363 - Han; Yongxin ;   et al.
2019-12-19
BENZO[b]THIOPHENE COMPOUNDS AS STING AGONISTS
App 20190337918 - Altman; Michael D. ;   et al.
2019-11-07
BENZO[b]THIOPHENE COMPOUNDS AS STING AGONISTS
App 20190337917 - Altman; Michael D. ;   et al.
2019-11-07
Sting Agonist Compounds
App 20190300513 - Altman; Michael D. ;   et al.
2019-10-03
Benzo[b]thiophene compounds as sting agonists
Grant 10,414,747 - Altman , et al. Sept
2019-09-17
Aryl acylsulfonamides as BLT1 antagonists
Grant 10,336,733 - Han , et al.
2019-07-02
Pyrazolopyrimidine inhibitors of IRAK4 activity
Grant 10,329,294 - Lim , et al.
2019-06-25
Pyrrolotriazine inhibitors of IRAK4 activity
Grant 10,329,295 - Lim , et al.
2019-06-25
Carboxamide inhibitors of IRAK4 activity
Grant 10,155,765 - Lim , et al. Dec
2018-12-18
Novel Compounds That Are Erk Inhibitors
App 20180319804 - Lim; Jongwon ;   et al.
2018-11-08
Aryl Acylsulfonamides As Blt1 Antagonists
App 20180305342 - Han; Yongxin ;   et al.
2018-10-25
Cyclic di-nucleotide compounds as sting agonists
Grant 10,106,574 - Altman , et al. October 23, 2
2018-10-23
Compounds that are ERK inhibitors
Grant 10,065,967 - Lim , et al. September 4, 2
2018-09-04
Cyclic Di-nucleotide Compounds As Sting Agonists
App 20180244712 - Altman; Michael D. ;   et al.
2018-08-30
Cyclic Di-nucleotide Compounds As Sting Agonists
App 20180237469 - Altman; Michael D. ;   et al.
2018-08-23
Thienopyrazine inhibitors of IRAK4 activity
Grant 10,040,802 - Lim , et al. August 7, 2
2018-08-07
Pyrrolopyridazine inhibitors of IRAK4 activity
Grant 10,040,798 - Lim , et al. August 7, 2
2018-08-07
Inhibitors of IRAK4 activity
Grant 9,969,749 - Altman , et al. May 15, 2
2018-05-15
Inhibitors of IRAK4 activity
Grant 9,943,516 - Altman , et al. April 17, 2
2018-04-17
BENZO[b]THIOPHENE COMPOUNDS AS STING AGONISTS
App 20180093964 - Altman; Michael D. ;   et al.
2018-04-05
Inhibitors of IRAK4 activity
Grant 9,932,350 - Altman , et al. April 3, 2
2018-04-03
Inhibitors of IRAK4 activity
Grant 9,926,330 - Altman , et al. March 27, 2
2018-03-27
Pyrrolopyridazine Inhibitors Of Irak4 Activity
App 20180051029 - LIM; JONGWON ;   et al.
2018-02-22
Pyrrolotriazine Inhibitors Of Irak4 Activity
App 20180051030 - LIM; JONGWON ;   et al.
2018-02-22
Pyrazolopyrimidine Inhibitors Of Irak4 Activity
App 20180051028 - LIM; JONGWON ;   et al.
2018-02-22
Thienopyrazine Inhibitors Of Irak4 Activity
App 20180051035 - LIM; JONGWON ;   et al.
2018-02-22
Carboxamide Inhibitors Of Irak4 Activity
App 20180051027 - LIM; JONGWON ;   et al.
2018-02-22
ERK inhibitors
Grant 9,884,048 - Siliphaivanh , et al. February 6, 2
2018-02-06
Novel Compounds That Are Erk Inhibitors
App 20170320882 - Lim; Jongwon ;   et al.
2017-11-09
Inhibitors Of Irak4 Activity
App 20170275297 - ALTMAN; MICHAEL D. ;   et al.
2017-09-28
Erk Inhibitors
App 20170266167 - Siliphaivanh; Phieng ;   et al.
2017-09-21
Inhibitors Of Irak4 Activity
App 20170247388 - ALTMAN; MICHAEL D. ;   et al.
2017-08-31
Compounds that are ERK inhibitors
Grant 9,745,307 - Lim , et al. August 29, 2
2017-08-29
Inhibitors Of Irak4 Activity
App 20170217981 - ALTMAN; MICHAEL D. ;   et al.
2017-08-03
Inhibitors Of Irak4 Activity
App 20170209446 - ALTMAN; MICHAEL D. ;   et al.
2017-07-27
Cyclic Di-nucleotide Compounds As Sting Agonists
App 20170044206 - Altman; Michael D. ;   et al.
2017-02-16
Imidazolyl analogs as syk inhibitors
Grant 9,487,504 - Lim , et al. November 8, 2
2016-11-08
Substituted Amidopyrazole Inhibitors Of Interleukin Receptor-associated Kinases (irak-4)
App 20160166576 - LIM; Jongwon ;   et al.
2016-06-16
Novel Compounds That Are Erk Inhibitors
App 20160068532 - Lim; Jongwon ;   et al.
2016-03-10
Pyrazolyl derivatives as Syk inhibitors
Grant 9,242,984 - Machacek , et al. January 26, 2
2016-01-26
Compounds that are ERK inhibitors
Grant 9,233,979 - Wilson , et al. January 12, 2
2016-01-12
Aminopyrimidinones as interleukin receptor-associated kinase inhibitors
Grant 9,221,809 - Seganish , et al. December 29, 2
2015-12-29
Novel Compounds That Are Erk Inhibitors
App 20150266895 - Wilson; Kevin J. ;   et al.
2015-09-24
Pyrazolyl Derivatives As Syk Inhibitors
App 20150191461 - Machacek; Michelle R. ;   et al.
2015-07-09
Imidazolyl Analogs As Syk Inhibitors
App 20150175575 - Lim; Jongwon ;   et al.
2015-06-25
Compounds that are ERK inhibitors
Grant 9,023,865 - Lim , et al. May 5, 2
2015-05-05
Pyrazolo[1,5-A]pyrimidines as mark inhibitors
Grant 8,946,237 - Lim , et al. February 3, 2
2015-02-03
Aminopyrimidinones As Interleukin Receptor-associated Kinase Inhibitors
App 20140329799 - Seganish; W. Michael ;   et al.
2014-11-06
Novel Compounds That Are Erk Inhibitors
App 20140296203 - Lim; Jongwon ;   et al.
2014-10-02
Aminopyrimidines as SYK Inhibitors
App 20140243290 - Altman; Michael D. ;   et al.
2014-08-28
Aminopyrimidines as Syk inhibitors
Grant 8,735,417 - Altman , et al. May 27, 2
2014-05-27
Imidazo[1,2-a]pyridines and imidazo[1,2-b]pyridazines as mark inhibitors
Grant 8,592,425 - Altman , et al. November 26, 2
2013-11-26
Aminopyrimidines as SYK inhibitors
Grant 8,551,984 - Altman , et al. October 8, 2
2013-10-08
Pyrazolo[1,5-a]pyrimidines As Mark Inhibitors
App 20130210838 - Lim; Jongwon ;   et al.
2013-08-15
Pyrazolo[1,5-a]pyrimidine derivatives
Grant 8,461,162 - Stanton , et al. June 11, 2
2013-06-11
Inhibitors of janus kinases
Grant 8,431,569 - Young , et al. April 30, 2
2013-04-30
Inhibitors of janus kinases
Grant 8,367,706 - Altman , et al. February 5, 2
2013-02-05
Aminopyrimidines As Syk Inhibitors
App 20120309735 - Altman; Michael D. ;   et al.
2012-12-06
Aminopyrimidines As Syk Inhibitors
App 20120277192 - Altman; Michael D. ;   et al.
2012-11-01
IMIDAZO[1,2-A]PYRIDINES AND IMIDAZO[1,2-b]PYRIDAZINES AS MARK INHIBITORS
App 20120010209 - Altman; Michael D. ;   et al.
2012-01-12
Aminopyrimidines As Syk Inhibitors
App 20110245205 - Altman; Michael D. ;   et al.
2011-10-06
PYRAZOLO[1,5-a]PYRIMIDINE DERIVATIVES
App 20100305091 - Stanton; Matthew G. ;   et al.
2010-12-02
Inhibitors Of Janus Kinases
App 20100267709 - Young; Jonathan R. ;   et al.
2010-10-21
Inhibitors Of Janus Kinases
App 20100256097 - Altman; Michael ;   et al.
2010-10-07
Tyrosine kinase inhibitors
Grant 7,790,739 - Lim , et al. September 7, 2
2010-09-07
Tyrosine Kinase Inhibitors
App 20090291941 - Dinsmore; Christopher J. ;   et al.
2009-11-26
Tyrosine Kinase Inhibitors
App 20090247565 - Lim; Jongwon ;   et al.
2009-10-01
Benzocycloheptapyridines as inhibitors of the receptor tyrosine kinase met
App 20090197908 - Dinsmore; Christopher J. ;   et al.
2009-08-06
Tyrosine kinase inhibitors
Grant 7,550,478 - Dinsmore , et al. June 23, 2
2009-06-23
Tyrosine Kinase Inhibitors
App 20090131423 - Dinsmore; Christopher J. ;   et al.
2009-05-21
Pyridin-4-ylamine compounds useful in the treatment of neuropathic pain
App 20070099950 - Lim; Jongwon ;   et al.
2007-05-03
Tyrosine kinase inhibitors
App 20060293358 - Dinsmore; Christopher J. ;   et al.
2006-12-28

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed